Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19
Clinical trial NCT04377503 · TERMINATED
Trial details
- NCT number
- NCT04377503
- Sponsor
- Hospital Sao Domingos
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-01
- Primary completion
- 2020-08-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.